General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes

The administration of high-dose clindamycin (CLI) along with penicillin is recommended for the treatment of streptococcal toxic-shock syndrome (STSS). However, we previously reported that a “subinhibitory dose” of CLI induced the expression of the NAD-glycohydrolase (NADase) exotoxin in an emm1-type...

Full description

Saved in:
Bibliographic Details
Main Authors: Ichiro Tatsuno, Masanori Isaka, Tadao Hasegawa
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Microbiology
Online Access:http://dx.doi.org/10.1155/2022/4767765
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551165912416256
author Ichiro Tatsuno
Masanori Isaka
Tadao Hasegawa
author_facet Ichiro Tatsuno
Masanori Isaka
Tadao Hasegawa
author_sort Ichiro Tatsuno
collection DOAJ
description The administration of high-dose clindamycin (CLI) along with penicillin is recommended for the treatment of streptococcal toxic-shock syndrome (STSS). However, we previously reported that a “subinhibitory dose” of CLI induced the expression of the NAD-glycohydrolase (NADase) exotoxin in an emm1-type Streptococcus pyogenes 1529 strain isolated from an STSS patient. In this study, we examine NADase induction by CLI treatment using an extracellular NADase activity assay instead of the previous two-dimensional gel electrophoresis assay. The examination revealed that CLI administration can induce NADase expression in a dose-dependent manner. We analyzed 23 CLI-susceptible strains (5 emm1 strains, 6 emm3 strains, 3 emm4 strains, 1 emm6 strain, 3 emm12 strains, 1 emm28 strain, and 4 emm89 strains), and 19 of the 23 strains showed similar NADase induction phenotypes to that shown in strain 1529. These results indicate that NADase induction by CLI treatment is not restricted to specific strains and it could be a standard phenotype among CLI-susceptible S. pyogenes strains. We also analyzed four CLI-resistant strains. All four strains showed increased extracellular NADase activities at high concentrations of CLI that did not inhibit bacterial growth. These results indicated that the subinhibitory dose of CLI was not the critical factor for NADase induction.
format Article
id doaj-art-14093699fa2f4bf783db20f68f44b644
institution Kabale University
issn 1687-9198
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Microbiology
spelling doaj-art-14093699fa2f4bf783db20f68f44b6442025-02-03T06:04:41ZengWileyInternational Journal of Microbiology1687-91982022-01-01202210.1155/2022/4767765General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenesIchiro Tatsuno0Masanori Isaka1Tadao Hasegawa2Department of BacteriologyDepartment of BacteriologyDepartment of BacteriologyThe administration of high-dose clindamycin (CLI) along with penicillin is recommended for the treatment of streptococcal toxic-shock syndrome (STSS). However, we previously reported that a “subinhibitory dose” of CLI induced the expression of the NAD-glycohydrolase (NADase) exotoxin in an emm1-type Streptococcus pyogenes 1529 strain isolated from an STSS patient. In this study, we examine NADase induction by CLI treatment using an extracellular NADase activity assay instead of the previous two-dimensional gel electrophoresis assay. The examination revealed that CLI administration can induce NADase expression in a dose-dependent manner. We analyzed 23 CLI-susceptible strains (5 emm1 strains, 6 emm3 strains, 3 emm4 strains, 1 emm6 strain, 3 emm12 strains, 1 emm28 strain, and 4 emm89 strains), and 19 of the 23 strains showed similar NADase induction phenotypes to that shown in strain 1529. These results indicate that NADase induction by CLI treatment is not restricted to specific strains and it could be a standard phenotype among CLI-susceptible S. pyogenes strains. We also analyzed four CLI-resistant strains. All four strains showed increased extracellular NADase activities at high concentrations of CLI that did not inhibit bacterial growth. These results indicated that the subinhibitory dose of CLI was not the critical factor for NADase induction.http://dx.doi.org/10.1155/2022/4767765
spellingShingle Ichiro Tatsuno
Masanori Isaka
Tadao Hasegawa
General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
International Journal of Microbiology
title General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
title_full General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
title_fullStr General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
title_full_unstemmed General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
title_short General Phenotype of NADase Induction by CLI Treatment in Streptococcus pyogenes
title_sort general phenotype of nadase induction by cli treatment in streptococcus pyogenes
url http://dx.doi.org/10.1155/2022/4767765
work_keys_str_mv AT ichirotatsuno generalphenotypeofnadaseinductionbyclitreatmentinstreptococcuspyogenes
AT masanoriisaka generalphenotypeofnadaseinductionbyclitreatmentinstreptococcuspyogenes
AT tadaohasegawa generalphenotypeofnadaseinductionbyclitreatmentinstreptococcuspyogenes